Background: Reductions in the volume of brain white matter are a common feature in schizophrenia and bipolar disorder while the association between white matter and polygenic schizophrenia-related risk is unclear. To look at the intermediate state between health and the full-blown disorder, we investigated this aspect in groups of patients before and after the onset of psychosis. Methods: On a 3 Tesla scanner, total and regional white matter volumes were investigated by structural magnetic resonance imaging (MRI) in the following groups: 37 at-risk mental state patients (ARMS), including 30 with no transition to psychosis (ARMS-NT) and 7 with a transition to psychosis (ARMS-T) pooled with 25 first episode psychosis (FEP) patients. These T 1 -weighted images were automatically processed with the FreeSurfer software and compared with an odds-ratio-weighted polygenic schizophrenia-related risk score (PSRS) based on the publicly available top white matter single-nucleotide polymorphisms. Results: We found no association, only a trend, between PSRS and white matter volume over all groups (β = 0.24, p = 0.07, 95% confidence interval = [-0.02 -0.49]). However, a higher PSRS was significantly associated with a higher probability of being assigned to the ARMS-T + FEP group rather than to the ARMS-NT group (β = 0.70, p = 0.02, 95% confidence interval = [0.14 -1.33]); there was no such association with white matter volume. Additionally, a positive
Introduction
Schizophrenia and bipolar disorder can be severe mental disorders with high heritability [1, 2] , high genetic relationship [3] and an overlap in symptomatology. However, the profile of common genetic variants that contribute to the susceptibility to schizophrenia and/or bipolar disorder are still under investigation. The Psychiatric Genomics Consortium (PGC) performed the largest study to date and identified 108 loci associated with schizophrenia [4] . Furthermore, it has been estimated that thousands of genetic variants with small effects are involved in the susceptibility to schizophrenia and bipolar disorder and might account for around 23% of the variation in liability to schizophrenia [5] [6] [7] . If the risk allele count of Single Nucleotide Polymorphisms (SNP) are combined into a single polygenic schizophreniarelated risk score, this might be associated with disease-characteristic endophenotypes that are more closely related to the biological processes than are diagnostic criteria [8] [9] [10] .
Another robust marker that is associated with schizophrenia and bipolar disorder is alteration in brain structure [11] [12] [13] . Moreover, in schizophrenia patients, reductions in white matter are largely driven (94%) by genetic factors [14] . Several studies have therefore investigated an association between white matter volume and a schizophrenia SNP score. Firstly, a publication by Terwisscha van Scheltinga identified 186 schizophrenia-associated SNPs associated with white matter volume in both schizophrenia patients (n=152) and healthy controls (n=142) [15] . Secondly, a study in healthy individuals (n=122) found no association between white matter volume and the same set of SNPs [16] . Thirdly, a study with schizophrenia and bipolar patients, first-degree relatives of schizophrenia patients (n=94) and healthy controls (n=89) found an association between 7 SNPs (not included in the above risk score) and white matter volume [17] . Fourthly, a study (n=1470) and its replication (n=2725) in healthy individuals again detected no association -in two and three independent cohorts, respectively -between white matter volume and SNPs from the PGC consortium [18, 19] .
To further investigate the potentially important association between white matter volume and the polygenic schizophrenia-related risk score (PSRS) in schizophrenia and bipolar disorder patients but not healthy controls, we investigated this aspect in groups of patients before and after the onset of psychosis. More specifically, the analysis included first-episode psychosis patients (FEP) experiencing their first episode of psychosis and at high clinical risk of psychosis [20] and at-risk mental state (ARMS) patients, who showed signs and symptoms that might precede a first psychotic episode [21] . We hypothesize that we would find and replicate the association between the 186 schizophrenia-associated risk score and total white matter volume in a cohort of ARMS and FEP patients. Furthermore, we also investigated the association between this PSRS and specific white matter regions.
Materials and Methods
Participants and clinical assessment ARMS and FEP patients included in this study were recruited, assessed and treated in the early detection of psychosis research program (Früherkennung von Psychosen; FePsy) at the University of Basel, Psychiatric University Clinics Basel, Switzerland [22, 23] . All individuals were assessed by the Basel Screening Instrument for Psychosis (BSIP) [24] , the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS) and the Global Assessment of Functioning (GAF), at the time of the MRI scan. We additionally obtained information on current and previous psychotropic medication, nicotine, and illegal drug consumption, using a semi-structured interview adapted from the Early Psychosis Prevention and Intervention Centre Drug and Alcohol Assessment Schedule (eppic.org.au).
ARMS was defined in accordance with the criteria of Yung and resulted in the inclusion of N = 37 ARMS individuals in the study, [24] The FEP patients (N = 25) met the operational criteria of Yung et al. [25] and fulfilled criteria for acute psychotic disorder according to ICD-10 or DSM-V but not for schizophrenia. For a more detailed description of the study procedure see Harrisberger et al. [26] All individuals were antipsychotic-naïve at the time of scanning, whereas 17 of the ARMS individuals were receiving antidepressants. 7 ARMS patients underwent the transition to psychosis within four years of MR scanning. 13 of our FEP patients were antipsychotic-naïve, 3 were antipsychotic-free and 9 were receiving antipsychotic medication at the time of scanning (two quetiapine, two risperidone, two olanzapine, one clozapine, one aripiprazole, one paliperidone). In the antipsychotic-free group, antipsychotic medication (two aripiprazole, one risperidone) had been stopped 4, 19 and 24 months previously, respectively. Antipsychotic dose was converted into chlorpromazine (CPZ) equivalents using the Suppl. Table ' Antipsychotic dose conversion' in Ho et al. [27] The mean chlorpromazine equivalents (standard deviation) were 250.70 mg (200.76). Of all FEP patients, 3 received only antidepressants alone and 4 were on combined treatment with antidepressants and antipsychotics. In this analysis, the patients were grouped into ARMS with no transition to psychosis (ARMS-NT) and ARMS with a transition to psychosis (ARMS-T) pooled with FEP patients.
Exclusion criteria were history of previous psychotic disorder, psychotic symptomatology secondary to an 'organic' disorder, psychotic symptoms associated with an affective psychosis or a borderline personality disorder, substance abuse according to International Statistical Classification of Diseases, 10th Revision (ICD-10) research criteria, head trauma, neurological illness, serious medical or surgical illness, age under 18 years, inadequate knowledge of the German language, and IQ less than 70 as measured by the Mehrfachwahl Wortschatz [Multiple Choice Vocabulary] Test Form B (MWT-B).
All participants provided written informed consent and received compensation for participating. The study has permission from the ethics committee of North-West and Central Switzerland (EKNZ).
MRI acquisition
All scans were performed at Basel University Hospital on a 3T magnetic resonance imaging (MRI) scanner (Siemens Magnetom Verio, Siemens Healthcare, Erlangen, Germany), using a 12-channel phased-array radio frequency head coil. For structural images, a 3D T 1 -weighted magnetization prepared rapid gradient echo (MPRAGE) sequence was used with the following parameters: an inversion time of 1,000 ms, flip angle = 8 degrees, TR = 2 s, TE = 3.37 ms, FOV = 25.6 cm, acquisition matrix = 256 x 256 x 176, resulting in 176 contiguous sagittal slices with 1x1x1 mm 3 isotropic spatial resolution. All scans were screened for gross radiological abnormalities by resident neuroradiologists.
Genotyping and Imputation DNA was extracted from whole blood samples using the QIAamp ® DNA Blood Maxi kit, according to standard procedures (Qiagen Inc., Chatsworth, CA). DNA samples were further processed on the Affymetrix ® Genome-Wide Human SNP Array 6.0, as described in the Genome-Wide Human SNP Nsp/Sty 6.0. User Guide (Affymetrix, Santa Clara, CA, USA) in one centralized microarray facility. Generation of SNP calls and array quality control were performed using the Affymetrix Genotyping Console Software 3.0 (Affymetrix Inc.). According to the manufacturer's recommendation, contrast quality control (QC) was chosen as QC metric, using the default value of 0.4. All samples passing QC criteria were subsequently genotyped using the Birdseed (v2) algorithm, leading to a total of 921,523 genotyped SNPs per sample. Appropriate SNP QC filtering was applied in PLINK 1.9 software, where the gender check in PLINK led to the exclusion of 3 individuals (Purcell S, Chang CC General Usage -PLINK 1.9.2015. https://www.cog-genomics.org/plink2/general usage) [28] . They were excluded prior to the analyses and are not included in the sample sizes shown.
Population stratification was assessed using principal component analysis implemented in the EIGENSTRAT software [29] to detect genotypic outliers -with default parameters: >6 standard deviations on any of the top ten principal components (PC) in five iterations -and corrected for potential population substructure by analyzing all array-based pruned, autosomal SNPs. Eight individuals were identified as outliers and therefore excluded from further analyses. They are not included in the sample sizes shown.
Prior to autosome-wide genotype imputation, haplotype estimation was performed using SHAPEITv2 [30] , allowing a maximum of 5% per individual and per SNP missing rate for observed markers. After pre-phasing, genotype imputation was performed using IMPUTE [30] v2.3.0, which imputes missing genotypes using a multi-population reference panel [31, 32] . The integrated variant callset of 1,092 individuals from the 1000 Genomes Project (release v3 in NCBI build 37/hg19 coordinates, March 2012) served as panel data (http://mathgen.stats.ox.ac.uk/impute/ALL_1000G_phase1integrated_v3_impute_macGT1. tgz). Only genotype calls exceeding a probability score of 90% were converted into genotype calls for statistical analysis using plink [33] .
PSRS calculation PSRS were calculated, following the suggestions of Wray et al. [34] , by taking LD pruned loci associated with white matter volume identified by Terwischa van Scheltinga et al., 2013 [15] . All 186 SNPs could be used to calculate the PSRS. 57 SNPs represented on the Affymetrix 6.0 Genotyping Array and 129 imputed SNPs were included (See Suppl. Table 2 [15]). In summary, the number of risk alleles per person was weighted for each SNP by the logarithm of its odds ratio as reported in the PGC SZ dataset [4] and summed across SNPs [7] using the PLINK 1.9 software (Purcell S, Chang CC General Usage -PLINK 1.9.2015. https:// www.cog-genomics.org/plink2/general usage and [28] ). The PSRS was then corrected for the first twenty genotypic PCs and the number of SNPs used to calculate the PSRS by using the z-transformed residuals of a linear regression.
Image processing
Total white matter volume was segmented from T 1 -weighted MPRAGE images with the freely available and validated segmentation software FreeSurfer software version 6.0.0 (http://surfer.nmr.mgh. harvard.edu) [35] and quality checked according to standardized ENIGMA protocols (http://enigma.ini.usc.edu/). Raw volumes for the total white matter volume were extracted as well as segmented volumes of 68 white matter volumes (34 left and 34 right) in white matter regions. From these white matter regions, the following 6 bilateral white matter regions were selected from a systematic review [36] : caudal and rostral anterior cingulate, entorhinal, parahippocampal, superior frontal and frontal pole white matter, left and right each. All were separately corrected for intracranial volume (ICV), age, gender and CPZ equivalents of antipsychotics, by using the z-transformed residuals of a linear regression. An outlier control resulted (mean ± 3.5 SD) in the exclusion of 1 individual.
Statistical Analysis
The R 3.3.2 software (R Core Team, 2013 "R: A language and Environment for Statistical Computing" http://www.R-project.org) with the packages stats was used for statistical, group-related analysis. Chi-square tests or t tests were used to test the distribution between diagnosis group and gender, handedness, CPZ equivalents, antipsychotics, antidepressants, alcohol consumption, cannabis consumption, or age, years of education, IQ, BPRS, BPRS positive symptoms cluster, BPRS negative symptoms cluster, SANS, GAF, smoking respectively. Values are presented as mean ± SD (see table 1 ). We combined several items of the BPRS into the following symptom clusters: Harrisberger et -negative (blunted affect (BPRS16), emotional withdrawal (BPRS17), motor retardation (BPRS18)), activation (elevated mood (BPRS7), excitement (BPRS21) and motor hyperactivity (BPRS23)) and -affect (depression (BPRS3), suicidality (BPRS4) and guilt (BPRS5)) [37] .
In addition, associations between clinical symptoms and PSRS or white matter volume were examined by linear regression analysis and corrected for multiple comparison. The relationship between corrected PSRS (corrected for the first twenty genotypic PCs and the number of SNPs used to calculate the PSRS) and the corrected white matter volume (corrected for ICV, age, gender and CPZ equivalents of antipsychotic dose) was assessed in a linear regression model. We then fitted a logistic regression using the generalized linear model function in R with diagnosis status as binary dependent variable and the corrected white matter volume and the corrected PSRS score as independent variables (both having similar variance between groups).
Results

Clinical and sociodemographic characteristics
There were no significant differences between the investigated groups with respect to gender (p = 0. Table 1) . Table 2 ) on the log odds was significant. Therefore, a higher PSRS score is associated with a higher likelihood that an individual would be assigned to the group of ARMS-T+FEP individuals than to the group of ARMS-NT individuals.
Association between PSRS, white matter volume and diagnosis
Furthermore, in 6 specified white matter regions (i.e. caudal and rostral anterior cingulate, entorhinal, parahippocampal, superior frontal and frontal pole white matter), there was no significant association with a PSRS.
Association between PSRS or white matter volume and clinical parameters
At the time of scanning, PSRS was positively associated with BPRS total score (t=3. 16, p=0 .0026, 95%CI = [0.14 -0.58]) in the pooled ARMS-NT/ARMS-T+FEP sample. Separate analysis within the two groups revealed only an association for ARMS-T+FEP (t=3.74, p=0.001, 95%CI = [0.28 -0.78]), but none for ARMS-NT only (t=-1.52, p=0.14, 95%CI = [-0.58 -0.09]) (Fig. 3) . Moreover, neither total white matter volume nor any of the 6 selected white matter regions were associated with clinical parameters. These results are corrected for multiple comparisons.
As there is a significant difference in age between the groups , age is plotted against the standardized residuals of the PSRS and against standardized residuals of the total white matter volume (Fig. 4) . Age is plotted against standardized residuals of the total white matter volume adjusted on each side separately for ICV, age, gender and CPZ equivalents and plotted against the estimated probability of the logistic regression. ARMS-NT, at-risk mental state, no transition; ARMS-T, at-risk mental state, with transition; CPZ, chlorpromazine; FEP, first-episode psychosis; PC, principal component; PSRS, Polygenic SchizophreniaRelated Risk Score; SNP, single-nucleotide polymorphism; WM, white matter volume.
Discussion
To our knowledge, this is the first study to analyze an association between a polygenic schizophrenia-related risk score, white matter volume and the onset of psychosis. In ARMS and FEP patients, we could not confirm an association between white matter volumes and PSRS, only trend. However, a higher PSRS was significantly associated with a higher probability of being assigned to the ARMS-T+FEP group than to the ARMS-NT group. No such association was found with white matter volume. In addition, we found a positive association between PSRS and the BPRS total score.
In contrast to previous publications with schizophrenia and bipolar disorder patients [14, 16] we found no association between this PSRS and white matter volume. However, the results are in line with publications analyzing the association in healthy individuals only.
[ [15] [16] [17] [18] . This patient sample consisted of ARMS and FEP patients, but without schizophrenia and bipolar disorder patients or healthy controls. One possible explanation of these findings is that the association is not present in the early stages of the disease. This is also reflected by the fact that white matter volume alterations are known to be present in schizophrenia and bipolar disorder patients and also the first-episode state [11, 13, [38] [39] [40] and less pronounced in ARMS [41] . Therefore, it might be speculated that white matter volume alterations occur only later in the development of the disorder, and are not detectable in this pooled patient cohort.
Although this genetic risk score was specifically selected to be associated with both white matter volume and schizophrenia [15] , we could not detect this association in our sample. Nevertheless, we could show that this PSRS is associated with a higher probability of being in an ARMS with subsequent transition to psychosis or already being an FEP patient. The association with the early disease status, before the onset of schizophrenia or bipolar disorder, might be an indicator not only for a greater risk for schizophrenia but more importantly for the actual onset of psychosis, even in the ARMS. This might show that a higher schizophrenia-specific risk might be capable of separating ARMS-T from ARMS-NT in the early detection of psychosis. Bearing in mind that up to 22% (95% 17%-26%) of ARMS patients undergo transition to psychosis within 3 years after the first presentation to clinical services [42] (see the meta-analytical eFig. 4), it might be speculated that with our transition rate of 23% four more patients in our sample with a high PSRS might exhibit a transition to psychosis. Our result indicated that ARMS-T and FEP share more schizophrenia-associated alleles than ARMS-NT and thus this might be a similarity marker for actual transition to psychosis in the ARMS patients. Understanding the genetic markers of impending vulnerability for psychosis in ARMS samples is of paramount relevance, given the poor research in this area. Indeed a recent meta-analysis of risk factors for psychosis within ARMS samples found no established genetic factors [43] .
Additionally, a higher PSRS was associated with higher BPRS total score in the whole sample of patients and also in ARMS-T+FEP only, but not in ARMS-NT only. This positive association between a PSRS and the widely-used scale for assessing psychotic symptoms might provide genetic evidence for actual similarity of ARMS-T with FEP. Moreover, this result might also indicate that ARMS-T plus FEP together are genetically similar to schizophrenia and bipolar disorder patients. Vice versa, the absence of an association in the ARMS-NT group might indicate once again that the genetic basis is not shared with PSRS. This is consistent with the concept of a psychosis continuum, as the genetic liability is also found in another quantitative trait which composes disorder, namely the psychotic symptoms [44] .
Polygenic scores could be useful to investigate the associations between disease risk and severity of illness,symptoms and early treatment or later functional outcomes [45] . This method could potentially be used to stratify clinical high-risk (CHR) populations into groups with shared genetic features, to identify those CHR individuals who would benefit from early therapeutic interventions. Future imaging genomics studies with larger samples may therefore not only lead to the discovery of biological pathways and links between genetic factors and alterations in brain networks [46] , but also become a major predictive tool in the investigation of the early intervention of psychiatric disorder [47] .
Limitations Some limitations to our study must be kept in mind. Firstly, the sample size is moderately small. However, confounding biases in this difficult-to-collect cohort are relatively unlikely, due to the relatively homogenous genetic background and clinical characteristics, such as disease duration [48] . Additionally, small samples can make use of polygenic risk scores derived from large GWAS which generate robust estimators [49] . Secondly, replication studies are needed to evaluate this association further by meta-analytic procedures and gain insight into the presence or absence of an effect in the early stages of psychosis. Thirdly, the explained variance in liability to schizophrenia due to the PSRS is small. Therefore, only be speculated about genetic differences between ARMS-NT and ARMS-T+FEP. The actual differences need further investigation. Fourthly, future studies might analyze diffusion tensor imaging (DTI) data rather than 3D T 1 -weighted MPRAGE data. Then, in a SDM meta-analysis [50] it was estimated that fractional anisotropy analyses may be more sensitive to identifying changes in white matter than VBM analyses. Fifthly, we are aware that no conclusion can be drawn from this study regarding non-affective versus affective psychoses, as the aim was to include patients with a first psychotic episode, independent of the underlying diagnosis according to ICD/DSM classification systems. Sixthly, due to the focus on the potential association between white matter volume and the polygenic schizophrenia-related risk score (PSRS) this study does not include a healthy control group but patients before and after the onset of psychosis. Finally, although there is a significant difference in age between the groups, we showed in previous study of grey matter volume and cortical thickness a similar pattern of structural alterations in ARMS and FEP [51] . However, this will not exclude the possibility that ARMS-NT patients will develop to ARMS-T or even FEP patients during the time-course.
Conclusion
In summary, this is the first analysis to evaluate the impact of white matter volume and a PSRS on the onset of psychosis. Although we could not confirm an association, we report that greater values of PSRS are associated with ARMS-T and FEP status than with ARMS-NT. Moreover, the PSRS was associated with BPRS total score. These results might indicate that ARMS-T and FEP patients have a higher genetic risk for schizophrenia than ARMS-NT. This aspect should be investigated in further studies analyzing the prediction of psychosis from the at-risk mental state.
